Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-29 @ 4:46 AM
Study NCT ID:
NCT05780034
Status:
RECRUITING
Last Update Posted:
2025-10-02
First Post:
2023-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Sponsor:
Accutar Biotechnology Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-10
First Submit QC Date:
None
Study First Post Date:
2023-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-29
Last Update Post Date:
2025-10-02
Last Update Post Date Type:
ESTIMATED